Related Experiment Video
Updated: Mar 13, 2026

Formulation and Characterization of Bioactive Agent Containing Nanodisks
Published on: March 17, 2023
Core-shell column Tanaka characterization and additional tests using active pharmaceutical ingredients
Jufang Wu Ludvigsson1, Anders Karlsson1, Viktor Kjellberg1
1Pharmaceutical Technology and Development, AstraZeneca R&D Gothenburg, Mölndal, Sweden.
Abstract:
In the last decade, core-shell particles have gained more and more attention in fast liquid chromatography separations due to their comparable performance with fully porous sub-2 μm particles and their significantly lower back pressure. Core-shell particles are made of a solid core surrounded by a shell of classic fully porous material. To embrace the developed core-shell column market and use these columns in pharmaceutical analytical applications, 17 core-shell C18 columns purchased from various vendors with various dimensions (50 mm × 2.1 mm to 100 mm × 3 mm) and particle sizes (1.6-2.7 μm) were characterized using Tanaka test protocols. Furthermore, four selected active pharmaceutical ingredients were chosen as test probes to investigate the batch to batch reproducibility for core-shell columns of particle size 2.6-2.7 μm, with dimension of 100 × 3 mm and columns of particle size 1.6 μm, with dimension 100 × 2.1 mm under isocratic elution. Columns of particle size 2.6-2.7 μm were also tested under gradient elution conditions. To confirm the claimed comparable efficiency of 2.6 μm core-shell particles as sub-2 μm fully porous particles, column performances of the selected core-shell columns were compared with BEH C18 , 1.7 μm, a fully porous column material as well.
Related Concept Videos
Pharmaceutical Alternatives: Polymorphic Form-Related and Particle Size-Related Therapeutic Nonequivalence
Drug Dissolution: Requirements and Profile Comparison
Site-Targeted Drug Delivery Systems: Polymeric Carriers
Pharmaceutical Alternatives: Excipients and Impurities-Related Therapeutic Nonequivalence
Modified-Release Drug Delivery Systems: Drug Release Characteristics
Formulation and Manufacturing Process: Physical Attributes of Generic Tablets and Capsules

